AUTOINJEKTOR

European patent · EP2885025 · In force

Register entry

Publication number
EP2885025
Application number
EP13750017
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 12, 2013
Published
Jun 24, 2015
Granted
May 11, 2022
Protection ends at the latest
Aug 11, 2033
Next annual fee due
Aug 31, 2027
IPC classes
A61M 5/20 (2006.01)
A61M 5/24 (2006.01)
A61M 5/32 (2006.01)
A61M 5/42 (2006.01)
A61M 5/315 (2006.01)
Priority
EP 12180577 15.08.2012
PCT application
PCT/EP2013/066775 12.08.2013
PCT publication
WO2014/026937 20.02.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Mar 22, 2023

    Change

    Published in Swissreg on 22.03.2023

  6. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  7. May 11, 2022

    Granted

    Published in Swissreg on 11.05.2022

Parties

Holder

Sanofi-Aventis Deutschland GmbH

Brüningstraße 50, 65929 Frankfurt am Main, DE

Inventor

MCGINLEY, Ryan Anthony

Melbourn, Herts SG8 6DP, GB

CROSS, David

Hertfordshire SG6 2AR, GB

JENNINGS, Douglas Ivan

Hertfordshire SG8 7XU, GB

HENDERSON, Charley

Cambridgeshire CB1 2PF, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.